Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma.
Saved in:
| Title: | Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma. |
|---|---|
| Authors: | Thummalapalli R; Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA., Sena LA; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Probasco JC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gladstone DE; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2020 Jan; Vol. 61 (1), pp. 228-230. Date of Electronic Publication: 2019 Sep 10. |
| Publication Type: | Case Reports; Letter |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2019.1658104 |
